MicroRNA‐494 within an oncogenic microRNA megacluster regulates G 1 /S transition in liver tumorigenesis through suppression of mutated in colorectal cancer-Reference-Cited by-同舟云学术

MicroRNA‐494 within an oncogenic microRNA megacluster regulates G 1 /S transition in liver tumorigenesis through suppression of mutated in colorectal cancer

Published:2013-11-22 Issue:1 Volume:59 Page:202-215
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lim Lionel¹²,Balakrishnan Asha²³,Huskey Noelle¹²,Jones Kirk D.⁴,Jodari Mona¹,Ng Raymond⁵,Song Guisheng⁵,Riordan Jesse⁶,Anderton Brittany¹²,Cheung Siu‐Tim⁷,Willenbring Holger⁵⁸,Dupuy Adam⁶,Chen Xin⁸⁹,Brown David¹⁰,Chang Aaron N.¹¹,Goga Andrei¹²⁸

Affiliation:

1. Department of Cell & Tissue BiologyUniversity of California San FranciscoSan Francisco CA

2. Department of MedicineUniversity of California San FranciscoSan Francisco CA

3. Department of GastroenterologyHepatology and EndocrinologyHannover Medical SchoolHannover Germany

4. Department of PathologyUniversity of California San FranciscoSan Francisco CA

5. Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell ResearchUniversity of California San FranciscoSan Francisco CA

6. Anatomy and Cell BiologyUniversity of IowaIowa City IA

7. Department of SurgeryThe University of Hong Kong Hong Kong

8. Liver CenterUniversity of California San FranciscoSan Francisco CA

9. Department of Bioengineering and Therapeutic SciencesUniversity of California San FranciscoSan Francisco CA

10. Mirna Therapeutics, Inc.Austin TX

11. Baylor Institute for Immunology ResearchDallas TX

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.26662

Reference44 articles.

1. Primary liver cancer: Worldwide incidence and trends

2. Etiology-dependent molecular mechanisms in human hepatocarcinogenesis

3. Analysis of ODC and c-myc gene expression in hepatocellular carcinoma by in situ hybridization and immunohistochemistry.

4. Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo

5. Ubiquitous Activation of Ras and Jak/Stat Pathways in Human HCC

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA miR-20a-5p targets CYCS to inhibit apoptosis in hepatocellular carcinoma;Cell Death & Disease;2024-06-27

2. Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response;Cancers;2024-02-13

3. microRNA-382 as a tumor suppressor? Roles in tumorigenesis and clinical significance;International Journal of Biological Macromolecules;2023-10

4. MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma;Journal of Experimental & Clinical Cancer Research;2023-06-10

5. Downregulation of microRNA‑494 inhibits cell proliferation in lung squamous cell carcinoma via the induction of PUMA‑α‑mediated apoptosis;Experimental and Therapeutic Medicine;2023-04-11